...
首页> 外文期刊>American Family Physician >Childhood and adolescent depression.
【24h】

Childhood and adolescent depression.

机译:童年和青少年抑郁症。

获取原文
获取原文并翻译 | 示例

摘要

Major depression affects 3 to 5 percent of children and adolescents. Depression negatively impacts growth and development, school performance, and peer or family relationships and may lead to suicide. Biomedical and psychosocial risk factors include a family history of depression, female sex, childhood abuse or neglect, stressful life events, and chronic illness. Diagnostic criteria for depression in children and adolescents are essentially the same as those for adults; however, symptom expression may vary with developmental stage, and some children and adolescents may have difficulty identifying and describing internal mood states. Safe and effective treatment requires accurate diagnosis, suicide risk assessment, and use of evidence-based therapies. Current literature supports use of cognitive behavior therapy for mild to moderate childhood depression. If cognitive behavior therapy is unavailable, an antidepressant may be considered. Antidepressants, preferably in conjunction with cognitive behavior therapy, may be considered for severe depression. Tricyclic antidepressants generally are ineffective and may have serious adverse effects. Evidence for the effectiveness of selective serotonin reuptake inhibitors is limited. Fluoxetine is approved for the treatment of depression in children eight to 17 years of age. All antidepressants have a black box warning because of the risk of suicidal behavior. If an antidepressant is warranted, the risk/benefit ratio should be evaluated, the parent or guardian should be educated about the risks, and the patient should be monitored closely (i.e., weekly for the first month and every other week during the second month) for treatment-emergent suicidality. Before an antidepressant is initiated, a safety plan should be in place. This includes an agreement with the patient and the family that the patient will be kept safe and will contact a responsible adult if suicidal urges are too strong, and assurance of the availability of the treating physician or proxy 24 hours a day to manage emergencies.
机译:严重抑郁症影响了3%至5%的儿童和青少年。抑郁症会对成长和发展,学校表现以及同伴或家庭关系产生负面影响,并可能导致自杀。生物医学和社会心理风险因素包括抑郁症的家族病史,女性,童年遭受虐待或忽视,生活压力大和慢性病。儿童和青少年抑郁症的诊断标准与成人相同。但是,症状表达可能随发育阶段而变化,并且某些儿童和青少年可能难以识别和描述内部情绪状态。安全有效的治疗要求准确的诊断,自杀风险评估和使用循证疗法。当前文献支持认知行为疗法用于轻度至中度儿童期抑郁症。如果没有认知行为疗法,可以考虑使用抗抑郁药。抗抑郁药,最好与认知行为疗法相结合,可考虑用于严重抑郁症。三环类抗抑郁药通常无效,可能会产生严重的不良反应。选择性5-羟色胺再摄取抑制剂有效性的证据有限。氟西汀被批准用于治疗8至17岁儿童的抑郁症。由于存在自杀行为的风险,所有抗抑郁药均带有黑框警告。如果需要抗抑郁药,则应评估风险/获益比,应教育父母或监护人有关风险,并对患者进行密切监控(例如,第一个月每周一次,第二个月每隔一周一次)用于紧急治疗。在开始抗抑郁药治疗之前,应制定安全计划。这包括与患者及其家属达成的协议,即如果自杀倾向太强烈,患者将得到安全保护并会与负责任的成年人取得联系,并保证治疗医生或代理每天24小时有空来处理紧急情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号